Aditxt subsidiary Pearsanta engages Spartan Capital for planned IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technolo
July 29, 2025 9:00 AM EDTPlanned IPO Aligns with Aditxts Acquire, Build and Capitalize (ABC) Monetization Framework
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today announced that its subsidiary, Pearsanta, Inc., (Pearsanta) has engaged Spartan Capital Securities, LLC (Spartan) as lead underwriter for its planned Initial Public Offering (IPO). This marks an important milestone in Aditxts Acquire, Build, and Capitalize (ABC) strategy, which is designed to accelerate the growth of innovative health companies.
Spartan will serve as Pearsantas exclusive... More



